VeriMomartemisia annua extract hamilelikte güvenli mi?
Artemisia annua extracts can contain artemisinin-class compounds, which produce severe embryotoxicity and developmental effects in multiple animal species; WHO and systematic reviews cite animal embryotoxicity/teratogenicity for artemisinin derivatives and advise caution in early pregnancy. There is no EU Annex II/III ban or harmonised CLP for the botanical extract itself, but the demonstrated animal reproductive toxicity of artemisinin (a likely component) justifies a 'suspected' reproductive hazard. (Sources: WHO nonclinical overview; systematic reviews and PubMed reviews).
Hamilelikte artemisia annua extract yerine kullanılabilecek güvenli alternatifler | VeriMom
Related ingredients
Frequently asked questions
- artemisia annua extract hamilelikte güvenli mi?
- Artemisia annua extracts can contain artemisinin-class compounds, which produce severe embryotoxicity and developmental effects in multiple animal species; WHO and systematic reviews cite animal embryotoxicity/teratogenicity for artemisinin derivatives and advise caution in early pregnancy. There is no EU Annex II/III ban or harmonised CLP for the botanical extract itself, but the demonstrated animal reproductive toxicity of artemisinin (a likely component) justifies a 'suspected' reproductive hazard. (Sources: WHO nonclinical overview; systematic reviews and PubMed reviews).
- artemisia annua extract emzirirken güvenli mi?
- Direct data on transfer of Artemisia annua extract or artemisinin into human milk are limited. Given the known animal embryo/foetal effects for artemisinin derivatives, a theoretical/class-based concern exists for breastfeeding exposure (precautionary), but there is insufficient direct evidence of harm via breastmilk in humans. Exposure from topical cosmetic use is expected to be low but measurable. (Sources: WHO review; clinical reviews summarising limited human/breastfeeding data).
- artemisia annua extract bebek cildi için güvenli mi?
- No infant-specific safety studies for topical Artemisia annua extract were found. Because the extract may contain artemisinin-class molecules that have demonstrated systemic embryotoxic mechanisms (affecting primitive erythroblasts and angiogenesis) and because infant skin has higher absorption per kg, the hazard and mechanistic concern are carried over from adult data (h=2, m=2) while exposure is increased by one category for infants (e increased). There is no evidence (e.g., harmonised CLP or EU ban) specific to cosmetic topical use to lower this concern. (Sources: WHO, systematic reviews, CosIng/EU listings, EWG).
- VeriMom artemisia annua extract nasıl puanlıyor?
- VeriMom artemisia annua extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 40/100 (orta risk) olarak puanlar.
- Hamilelikte artemisia annua extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.